Bednar and colleagues demonstrated that a TLR4-agonist monoclonal antibody, TLR4–MD-2, was able to halt and reverse fulminant T1D by inducing APC tolerance to pathogen in NOD mice (62). Here, TLR4 is linked to type 1 diabetes mellitus.